Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Dosing for combination treatment with anti-CD20/anti-CD3 bispecific antibody and anti-CD79B antibody drug conjugate

US Patent 12195547 · Granted Jan 14, 2025

Assignee

Inventors

View full patent text on Google Patents →